Dermatofibrosarcoma protuberans
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
Dermatofibrosarcoma protuberans | |
---|---|
Synonyms | DFSP |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Slow-growing skin nodule, often on the trunk or limbs |
Complications | Local recurrence, rarely metastasis |
Onset | Typically between 20 and 50 years of age |
Duration | Chronic |
Types | N/A |
Causes | Genetic mutation involving chromosome 17 and chromosome 22 |
Risks | Previous trauma to the skin, genetic predisposition |
Diagnosis | Biopsy, Histopathology |
Differential diagnosis | Dermatofibroma, Keloid, Lipoma, Melanoma |
Prevention | N/A |
Treatment | Surgical excision, Mohs micrographic surgery, Radiation therapy |
Medication | Imatinib for unresectable or metastatic cases |
Prognosis | Generally good with complete excision |
Frequency | 1 in 100,000 to 1 in 1,000,000 per year |
Deaths | Rare |
Other Names:
DFSP; Giant cell fibroblastoma; Familial dermatofibrosarcoma protuberans (subtype); Metastatic dermatofibrosarcoma protuberans (subtype)
Dermatofibrosarcoma protuberans is an uncommon cancer in which tumors arise in the deeper layers of skin. The tumor usually starts as a small, firm patch of skin; it may be purplish, reddish, or flesh-colored. It is commonly found on the torso, usually in the shoulder and chest area.
The tumor typically grows slowly but has a tendency to recur after being removed. It rarely spreads to other parts of the body.
These tumors are related to giant cell fibroblastomas.
Cause
The cause of DFSP is unknown but an injury to the affected skin may be a predisposing factor.Trauma at the affected site has been reported in approximately 10-20% of patients.
Genetics and inheritance
Recent advances have shown that in approximately 90% of cases, dermatofibrosarcoma protuberans is associated with a rearrangement (translocation) of genetic material between chromosomes 17 and 22 which results in the fusion of two genes. The fused gene produces a protein which some believe may stimulate cells to multiply, leading to the tumor formation seen in dermatofibrosarcoma protuberans. This type of gene change is generally found only in tumor cells and is not inherited.
Symptoms
or most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms
- Erythema
- Fibrosarcoma
- Neoplasm of the skin(Skin tumors)
- Subcutaneous nodule(Firm lump under the skin)
- Thickened skin(Thick skin)
30%-79% of people have these symptoms
- Skin ulcer(Open skin sore)
Diagnosis
DFSP is a malignant tumor diagnosed with a biopsy, when a portion of the tumor is removed for examination. In order to ensure that enough tissue is removed to make an accurate diagnosis, the initial biopsy of a suspected DFSP is usually done with a core needle or a surgical incision. Magnetic resonance imaging (MRI) is more sensitive addressing the depth of the invasion on some types of DFSP, particularly large or recurring tumors.
Treatment
Treatment is primarily surgical(Mohs surgery), with chemotherapy and radiation therapy used if clear margins are not acquired. The medication(s) listed below have been approved by the Food and Drug Administration (FDA) as orphan products for treatment of this condition.
- Imatinib mesylate (Brand name: Gleevec®)Treatment of adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP)
Prognosis
Regular follow-up is needed after tumor removal to monitor for recurrence. Local recurrences arise in 11-20% of cases, usually within three years of the initial surgery. Despite being locally aggressive, the tumor spreads to other parts of the body (metastasizes) in only 5% of cases. A small subset of patients with DFSP have a more aggressive variant known as fibrosarcomatous dermatofibrosarcoma protuberans or FS-DFSP. FS-DFSP tumors are more likely to metastasize than the tumors in other types of dermatofibrosarcoma protuberans.
Additional images
Subcutaneous tissue infiltration (i.e. "honeycomb" growth pattern)
DFSP formed both by fibroblastic and histiocytic elements
Hemosiderin deposits beneath the tumour
Immunostain positive for CD34
Skin cancer of the dermis | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Chromosome abnormalities | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NIH genetic and rare disease info
Dermatofibrosarcoma protuberans is a rare disease.
Rare and genetic diseases | ||||||
---|---|---|---|---|---|---|
Rare diseases - Dermatofibrosarcoma protuberans
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju, Prab R. Tumpati, MD